(Q43252674)

17 November 2017

title

Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy (English)

1 reference

17 November 2017

0 references

P J Modrego

1

1 reference

17 November 2017

N Fayed

2

1 reference

17 November 2017

J M Errea

3

1 reference

17 November 2017

C Rios

4

1 reference

17 November 2017

M A Pina

5

1 reference

17 November 2017

M Sarasa

6

1 reference

17 November 2017

publication date

28 October 2009

1 reference

European Journal of Neurology

17 November 2017

published in

1 reference

17 November 2017

volume

17

1 reference

17 November 2017

issue

3

1 reference

17 November 2017

page(s)

405-412

1 reference

describes a project that uses

17 November 2017

1 reference

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

21 January 2018

Excitotoxic cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Comparison of donepezil and memantine for protective effect against amyloid-beta(1-42) toxicity in rat septal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

The effect of drugs for Alzheimer disease assessed by means of neuroradiological techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

1H MR spectroscopy using TE averaged PRESS: a more sensitive technique to detect neurodegeneration associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Brain proton spectroscopy in dementia: an aid to clinical diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02816.X

10.1111/J.1468-1331.2009.02816.X

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference